|
This session highlights three major group visit models, their respective strengths and weaknesses, and how to make full use of them in practices and in comprehensive chronic illness population management programs. The cost, efficiency, and quality benefits of group visits in a chronic illness treatment program will be described. A new model for maximizing use of group visits will be reviewed.
After this presentation you will be able to:
- Discuss a new paradigm for treating chronic illness that makes full use of group visits to enhance quality and efficiency while containing costs.
- Articulate how to maximize use of group visits in chronic disease management.
- Describe three group visit models, their strengths and weaknesses, and how to best use them in chronic illness population management programs.
Edward B. Noffsinger, PhD, Independent Consultant and Former Director of Clinical Access Improvement, Palo Alto Medical Foundation |
|
|
|